Rare Pre-IPO Opportunity in Med-Tech Backed by Former President of Oraclevia Type a message

Pre-IPO Investment Alert: Rare Opportunity to Buy a Tiny Med-tech Backed by Former Oracle President Fellow Investor, If you ever had a gut feeling that the stock market was rigged to favor those "in-the-know", you were right. Think about it... We're stuck buying stocks on the open market -- after they've gone public... after Wall Street's driven prices higher. Sure, you can still make a bit of money. But the ULTIMATE way to profit is to get in on a company before it goes public, when you can buy it for virtually pennies on the dollar. It's how early investors made 3,000% gains the day Google went public... How the first financial backers of eBay made 765X their investment... And it's even how a guy named Peter Thiel made 2,000-TIMES his initial private investment after Facebook's IPO. Now, usually this kind of investing is only reserved for the “well-connected” or super-rich. But not today... A little-known investment platform is "fighting for the little guy" and giving everyday investors special access to an institutional-grade, pre-IPO opportunity. Here are the highlights: The company is backed one of the biggest names and most successful men in tech history: Ray Lane, the former President of Oracle (ORCL:NYSE). It's developed a groundbreaking, state-of-the-art augmented reality technology that could revolutionize the entire $23.5 billion cosmetic surgery industry. And it’s partnered with Mentor Worldwide, the world’s largest implant company and a member of the Johnson & Johnson (JNJ:NYSE) family of companies, giving it immediate access to thousands of surgery centers worldwide. Listen, in times like this you want to invest with the smartest people in the business -- people like Ray Lane. Ray headed Oracle in the 1990’s and while there, ORCL’s market cap shot-up more than 40-fold. He grew revenues from $800 million to over $10 billion, and he played a key role in transforming the company into the juggernaut it is today. This is your chance to invest alongside him in an early-stage startup.  It’s rare for everyday investors to get access to a pre-IPO opportunity like this. Don’t miss out. Invest now. Your pre-IPO experts, PS. Making an investment is easy. No special brokerage account needed. Simply click to invest and fill in your information. The whole process takes less than five minutes. You can even lock-in your investment after market hours or on the weekend. It’s almost like shopping on Amazon.

The above is a paid advertisement. StockEarnings.com is not affiliated with nor does it endorse any trading system, newsletter or other similar service. StockEarnings.com does not assure or verify any performance claims made by such systems, newsletters or services. Trading involves a significant and substantial risk of loss and may not be suitable for everyone. You should only trade with money you can afford to lose. There is no assurance that you will gain from your trading activity and it is possible that you may lose all of, or if trading on margin more than, your investment. Some of the results shown may be based on simulated performance. SIMULATED OR HYPOTHETICAL PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE THE RESULTS SHOWN IN AN ACTUAL PERFORMANCE RECORD, SUCH RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, BECAUSE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MY HAVE UNDER OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED OR HYPOTHETICAL PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE GAINS OR LOSSES SIMILAR TO THOSE SHOWN. Past performance is not necessarily indicative of future performance. This brief statement cannot disclose all the risks and other significant aspects of trading. You should carefully study trading and consider whether such activity is suitable for you in light of your circumstances and financial resources before you trade. This message is considered by regulation to be a commercial and advertising message. This is a permission-based message. You are receiving this email either because you opted-in to this subscription or because you have a prior existing relationship with StockEarnings.com or one of its subsidiaries, and previously provided your email address to us. This email fully complies with all laws and regulations. If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking on the unsubscribe or profile link and you will no longer receive this email. We will immediately redress any complaints you may have. If you have any questions, please send an email with your questions to info@stocksearning.com. If you would no longer like to receive StockEarnings partners and advertisers emails, you can click here to unsubscribe.